A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Gene Therapy

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301669PMID 11948376
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Independent Contributions of GR-1+ Leukocytes and Fas/FasL Interactions to Induce Apoptosis Following Interleukin-12 Gene Therapy in a Metastatic Model of Prostate Cancer

  2001cited by this paper
• Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer

  2000cited by this paper
• Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase

  1999cited by this paper
• Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases.

  1999cited by this paper
• Fas ligand is constitutively secreted by prostate cancer cells in vitro.

  1998cited by this paper
• Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.

  1998cited by this paper
• Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1

  1997cited by this paper
• An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice.

  1997cited by this paper
• Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.

  1997cited by this paper
• A “Distant” Bystander Effect of Suicide Gene Therapy: Regression of Nontransduced Tumors Together with a Distant Transduced Tumor

  1997cited by this paper
• Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments

  1997cited by this paper
• Adenovirus‐mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

  1997cited by this paper
• A Family of Bicistronic Vectors to Enhance Both Local and Systemic Antitumor Effects of HSVtk or Cytokine Expression in a Murine Melanoma Model

  1997cited by this paper
• Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models

  1996cited by this paper
• Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.

  1996cited by this paper
• Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival.

  1996cited by this paper
• Interleukin-12. Biologic activity, therapeutic utility, and role in disease.

  1995cited by this paper
• Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer.

  1995cited by this paper
• Combination gene therapy for liver metastasis of colon carcinoma in vivo.

  1995cited by this paper
• Interleukin-12. Biologic activity, therapeutic utility, and role in disease.

  1995cited by this paper
• Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

  1994cited by this paper
• Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.

  1994cited by this paper
• Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.

  1994cited by this paper
• Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

  1989cited by this paper

• CD3xHER2 bsAb‐Mediated Activation of Resting T‐cells at HER2 Positive Tumor Clusters Is Sufficient to Trigger Bystander Eradication of Distant HER2 Negative Clusters Through IFNγ and TNFα

  2025cites this paper
• Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy

  2024cites this paper
• Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses

  2022cites this paper
• Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy.

  2021cites this paper
• Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system.

  2019cites this paper
• Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro.

  2018cites this paper
• Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.

  2016cites this paper
• A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model

  2014cites this paper
• The role of MAPK in CD4(+) T cells toll-like receptor 9-mediated signaling following HHV-6 infection.

  2012cites this paper
• Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.

  2012cites this paper
• The role of interleukin‐12 on modulating myeloid‐derived suppressor cells, increasing overall survival and reducing metastasis

  2011cites this paper
• Molecular and traditional chemotherapy: a united front against prostate cancer.

  2010cites this paper
• Fas-Mediated Apoptotic Signaling in the Mouse Brain following Reovirus Infection

  2009cites this paper
• Induction of protective antitumor activity of tumor lysate-pulsed dendritic cells vaccine in RM-1 prostate cancer mode

  2009cites this paper
• Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control

  2008cites this paper
• TNF-alpha mediates pseudorabies virus-induced apoptosis via the activation of p38 MAPK and JNK/SAPK signaling.

  2008cites this paper
• Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas.

  2007cites this paper
• Novel gene-directed enzyme prodrug therapies against prostate cancer

  2006influential citation
• Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer.

  2006cites this paper
• Hepatocellular Carcinoma with Monocyte Chemoattractant Protein-1 Effects of Suicide Gene Therapy Combined Prolonged , NK Cell-Mediated Antitumor

  2006cites this paper
• Circumventing Recombination Events Encountered with Production of a Clinical-Grade Adenoviral Vector with a Double-Expression Cassette

  2006cites this paper
• Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.

  2006cites this paper
• Prolonged, NK Cell-Mediated Antitumor Effects of Suicide Gene Therapy Combined with Monocyte Chemoattractant Protein-1 against Hepatocellular Carcinoma

  2006cites this paper
• Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents

  2005cites this paper
• Versatile prostate cancer treatment with inducible caspase and interleukin-12.

  2005cites this paper
• Proapoptotic Strategy in Cancer Gene Therapy

  2005cites this paper
• the cytotoxicity of ganciclovir in HSV-tk transfected ovarian carcinoma cells

  2004cites this paper
• Do there exist synergistic antitumor effects by coexpression of herpes simplex virus thymidine kinase with cytokine genes on human gastric cancer cell line SGC7901?

  2004cites this paper
• Targeting gene therapy for prostate cancer.

  2004cites this paper
• Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer

  2004cites this paper
• Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma

  2004cites this paper
• Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase and cytokine genes expressed in gastric carcinoma cell line SGC7901.

  2004cites this paper
• Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.

  2004cites this paper
• The cyclin-dependent kinase inhibitor p21(cip1/waf1) enhances the cytotoxicity of ganciclovir in HSV-tk transfected ovarian carcinoma cells.

  2004cites this paper
• Suicide Gene Therapy

  2003cites this paper
• Viruses and the TNF-related cytokines, an evolving battle.

  2003cites this paper
• Current progress in adenovirus mediated gene therapy for patients with prostate carcinoma

  2003cites this paper
• Death and survival: viral regulation of TNF signaling pathways.

  2003cites this paper
• Prodrugs in genetic chemoradiotherapy.

  2003cites this paper
• Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression

  2003cites this paper
• Breakthroughs in cancer gene therapy.

  2003cites this paper
• Gene Therapy for the Treatment of Oral Squamous Cell Carcinoma

  2003cites this paper
• Differential killing of mismatch repair-deficient and -proficient cells: towards the therapy of tumors with microsatellite instability.

  2003cites this paper
• The potential for gene therapy in the treatment of autoimmune disease.

  2002cites this paper